American International Group, Inc. Rx Sight, Inc. Transaction History

American International Group, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$35.51 - $57.92 $4,261 - $6,950	-120 Reduced 0.85%	14,012 $722,000
Q4 2023 Feb 13, 2024	BUY	$20.91 - $40.9 $12,734 - $24,908	609 Added 4.5%	14,132 $569,000
Q3 2023 Nov 13, 2023	BUY	$27.05 - $33.37 $13,011 - $16,050	481 Added 3.69%	13,523 $377,000
Q2 2023 Aug 04, 2023	BUY	$16.37 - $28.9 $25,880 - $45,690	1,581 Added 13.79%	13,042 $375,000
Q1 2023 May 12, 2023	BUY	$12.58 - $16.68 $21,650 - $28,706	1,721 Added 17.67%	11,461 $191,000
Q4 2022 Feb 10, 2023	SELL	$9.93 - $14.2 $347 - $497	-35 Reduced 0.36%	9,740 $123,000
Q3 2022 Nov 14, 2022	BUY	$11.19 - $15.85 $1,533 - $2,171	137 Added 1.42%	9,775 $117,000
Q2 2022 Aug 12, 2022	BUY	$10.61 - $16.66 $9,856 - $15,477	929 Added 10.67%	9,638 $136,000
Q1 2022 May 13, 2022	BUY	$8.97 - $14.03 $38,436 - $60,118	4,285 Added 96.86%	8,709 $108,000
Q4 2021 Feb 11, 2022	SELL	$9.52 - $13.81 $1,256 - $1,822	-132 Reduced 2.9%	4,424 $50,000
Q3 2021 Nov 12, 2021	BUY	$11.85 - $17.32 $53,988 - $78,909	4,556 New	4,556 $58,000

231

31.3M

57.8K

12.5K

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $1.35B
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.